Skip to main content
. 2020 Aug 10;9(8):2586. doi: 10.3390/jcm9082586

Table A1.

Demographics and comorbidities by NSAID use.

No Yes Total
(n = 1168) (n = 54)
Sites
   Hospital A 146 (95.4) 7 (4.6) 153 (12.5)
   Hospital B 35 (81.4) 8 (18.6) 43 (3.5)
   Hospital C 117 (95.1) 6 (4.9) 123 (10.7)
   Hospital D 366 (96.3) 14 (3.7) 380 (31.1)
   Hospital E 109 (97.3) 3 (3.0) 112 (9.2)
   Hospital F 235 (95.5) 11 (4.5) 246 (20.1)
   Hospital G 112 (97.4) 3 (2.6) 115 (9.4)
   Hospital H 48 (96.0) 2 (4.0) 50 (4.1)
Age
   Under 65 yrs 362 (93.4) 25 (6.5) 387 (31.7)
   65 to 79 yrs 388 (95.8) 17 (4.2) 405 (33.1)
   Over 80 yrs 418 (97.2) 12 (2.8) 430 (35.2)
Sex
   Female 503 (94.6) 29 (5.5) 532 (43.5)
   Male 665 (96.4) 25 (3.6) 690 (56.5)
Smoking Status
   Never smokers 585 (94.5) 34 (5.5) 619 (50.7)
   Ex-smokers 475 (97.5) 12 (2.5) 487 (39.9)
   Current smokers 88 (91.7) 8 (8.3) 96 (7.9)
   Missing 20 0 20
Diabetes
   No 844 (95.2) 43 (4.9) 887 (72.6)
   Yes 319 (96.7) 11 (3.3) 330(27.0)
   Missing 5 0 5
Hypertension
   No 566 (93.9) 37 (6.1) 603 (49.4)
   Yes 597 (97.2) 17 (2.8) 614 (50.3)
   Missing 5 0 5
Coronary Artery disease
   No 899 (95.2) 45 (4.8) 944 (77.3)
   Yes 264 (96.7) 9 (3.3) 273 (22.3)
   Missing 5 0 5
Elevated CRP (>40)
   No 324 (97.0) 10 (3.0) 334 (27.3)
   Yes 825 (94.9) 44 (5.1) 888 (71.1)
   Missing 19 0 19
Renal function (eGFR < 60)
   No 699 (94.6) 10 (5.4) 739 (60.5)
   Yes 459 (97.0) 14 (3.0) 473 (38.7)
   Missing 10 0 10